Aarti Pharmalabs Reports Strong Q2 FY27 Results and Appoints New CFO
Aarti Pharmalabs Ltd · Others (Uncategorized) · 29 Oct 2026, 3:28 am
Aarti Pharmalabs Reports Strong Q2 FY27 Results and Appoints New CFO Aarti Pharmalabs reported consolidated revenue from operations of ₹61,045.10 lakhs for Q2 ended 30th Sep'26, up 45.9% YoY from ₹41,833.48 lakhs, while net profit jumped 248.8% YoY to ₹7,147.23 lakhs. Sequentially, revenue grew 13.9% QoQ from ₹53,579.69 lakhs, but net profit declined 6.1% QoQ. Diluted EPS stood at ₹7.87. Additionally, the company appointed Smt. Vibha Thakkar as CFO effective 31st Oct'26, following the resignation of Shri Piyush Lakhani effective 30th Oct'26. The board also recognized an exceptional demerger stamp duty provision of ₹204.00 lakhs.
Original exchange filing (PDF)
More announcements from Aarti Pharmalabs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company · 16 Nov 2026
- Q2 FY 27 Earnings Call Transcript · 04 Nov 2026
- Audio Recording of Conference Call for Investor and Analysts · 30 Oct 2026
- Q2 FY 2027 Investor Presentation · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
- Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
- Please find enclosed · 29 Oct 2026
